FI980023A0 - Sienilääke, siihen soveltuva yhdiste, menetelmä niiden valmistamiseksi ja menetelmä niiden käyttämiseksi - Google Patents

Sienilääke, siihen soveltuva yhdiste, menetelmä niiden valmistamiseksi ja menetelmä niiden käyttämiseksi

Info

Publication number
FI980023A0
FI980023A0 FI980023A FI980023A FI980023A0 FI 980023 A0 FI980023 A0 FI 980023A0 FI 980023 A FI980023 A FI 980023A FI 980023 A FI980023 A FI 980023A FI 980023 A0 FI980023 A0 FI 980023A0
Authority
FI
Finland
Prior art keywords
compound
preparation
antifungal agent
antifungal
agent
Prior art date
Application number
FI980023A
Other languages
English (en)
Swedish (sv)
Other versions
FI119357B (fi
FI980023A (fi
Inventor
Hiroki Kodama
Yoshimi Niwano
Kazuo Kanai
Masanori Yoshida
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of FI980023A0 publication Critical patent/FI980023A0/fi
Publication of FI980023A publication Critical patent/FI980023A/fi
Application granted granted Critical
Publication of FI119357B publication Critical patent/FI119357B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI980023A 1995-07-08 1998-01-07 Sienilääke, siihen soveltuva yhdiste ja menetelmä niiden valmistamiseksi FI119357B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP19617495 1995-07-08
JP19617495 1995-07-08
PCT/JP1996/001872 WO1997002821A2 (en) 1995-07-08 1996-07-05 Antifungal agent, compound therefor, process for producing the same
JP9601872 1996-07-05

Publications (3)

Publication Number Publication Date
FI980023A0 true FI980023A0 (fi) 1998-01-07
FI980023A FI980023A (fi) 1998-01-07
FI119357B FI119357B (fi) 2008-10-31

Family

ID=16353435

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980023A FI119357B (fi) 1995-07-08 1998-01-07 Sienilääke, siihen soveltuva yhdiste ja menetelmä niiden valmistamiseksi

Country Status (22)

Country Link
US (1) US5900488A (fi)
EP (1) EP0839035B1 (fi)
KR (1) KR100386491B1 (fi)
CN (1) CN1091596C (fi)
AT (1) AT407832B (fi)
CA (1) CA2226214C (fi)
CH (1) CH692045A5 (fi)
DE (1) DE19681478B4 (fi)
DK (1) DK176599B1 (fi)
ES (1) ES2137888B1 (fi)
FI (1) FI119357B (fi)
GB (1) GB2317615B (fi)
HK (1) HK1009751A1 (fi)
IL (1) IL122618A (fi)
IN (1) IN185384B (fi)
LU (1) LU90190B1 (fi)
NO (1) NO980055L (fi)
NZ (1) NZ311796A (fi)
SE (1) SE9800016L (fi)
TW (1) TW450969B (fi)
WO (1) WO1997002821A2 (fi)
ZA (1) ZA965745B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127397A (en) * 1996-12-10 2000-10-03 Nihon Nohyaku Co., Ltd. Optically active (R)-(E)-(4-substituted-phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylaceto nitrile derivative, antifungal composition comprising the same, and method for producing the same
JPWO2003105903A1 (ja) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 抗真菌医薬組成物
CA2489854A1 (en) * 2002-06-18 2003-12-24 Pola Chemical Industries Inc. Antifungal medicinal compositions
EP2005959B1 (en) * 2006-03-08 2015-01-21 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
US8268876B2 (en) * 2006-03-08 2012-09-18 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
MX2008011435A (es) 2006-03-08 2009-02-03 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
KR101184834B1 (ko) 2007-08-27 2012-09-20 니혼노야쿠가부시키가이샤 진균성 피부염용제
US20100204293A1 (en) 2007-09-05 2010-08-12 Pola Pharma Inc. Pharmaceutical composition
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
US20100173965A1 (en) 2007-09-05 2010-07-08 Pola Pharma Inc. Antifungal composition
US8193232B2 (en) * 2009-02-13 2012-06-05 Topica Pharmaceuticals, Inc. Anti-fungal formulation
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102387785B (zh) 2009-04-09 2017-08-25 宝丽制药股份有限公司 抗真菌药物组合物
KR101754697B1 (ko) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 항진균성 약제학적 조성물
JP5832451B2 (ja) 2010-06-11 2015-12-16 株式会社ポーラファルマ 抗真菌医薬組成物
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
WO2014041846A1 (en) * 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
EP2895479A1 (en) * 2012-09-14 2015-07-22 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
WO2014042231A1 (en) * 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
JP6254597B2 (ja) * 2013-01-28 2017-12-27 株式会社ポーラファルマ カンジダ等の病原微生物による疾患用の医薬組成物
EP2948145A1 (en) * 2013-01-28 2015-12-02 Pola Pharma Inc. Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
WO2015162271A1 (en) * 2014-04-25 2015-10-29 Syngenta Participations Ag Microbiocidal imidazole derivatives
WO2016092478A1 (en) 2014-12-12 2016-06-16 Glenmark Pharmaceuticals Limited Process for preparation of luliconazole
WO2017108972A1 (en) 2015-12-21 2017-06-29 Laboratorios Lesvi, S.L. Compounds of r-(-)-(e)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1 -imidazolylacetonitrile-ha (luliconazole-ha) as antifungals
CN106008166B (zh) * 2016-05-17 2018-09-25 上海福乐医药科技有限公司 一种手性2-氯-1-(2,4-二氯苯基)乙醇的工业化生产方法
EP3558304A2 (en) 2016-12-23 2019-10-30 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibitors of cytochrome p450 family 7 subfamily b member 1 (cyp7b1) for use in treating diseases
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
US10898470B1 (en) 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
WO2023131969A1 (en) * 2022-01-09 2023-07-13 Kimia Biosciences Limited Improved process for the preparation of luliconazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218736B1 (en) * 1985-10-10 1993-04-07 Nihon Nohyaku Co., Ltd. A ketene s,s-acetal derivative, a process for manufacturing thereof and a method for curing mycosis by administering it
ATE87920T1 (de) * 1985-10-09 1993-04-15 Nihon Nohyaku Co Ltd Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate.
JP3030780B2 (ja) * 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH0386337A (ja) * 1989-08-28 1991-04-11 Maeda Seisakusho:Kk エクスパンディングチャックを用いた多重巻締め機および多重巻締め方法
CN1038247C (zh) * 1990-05-16 1998-05-06 云南省建筑材料科学研究设计院 一种新型磷石膏胶结料
JP3038519B2 (ja) * 1992-01-28 2000-05-08 日本農薬株式会社 創傷治癒促進剤

Also Published As

Publication number Publication date
TW450969B (en) 2001-08-21
KR100386491B1 (ko) 2003-08-21
KR19990028772A (ko) 1999-04-15
DK176599B1 (da) 2008-10-27
US5900488A (en) 1999-05-04
FI119357B (fi) 2008-10-31
AU6319296A (en) 1997-02-10
DK1398A (da) 1998-01-07
GB2317615A (en) 1998-04-01
NO980055D0 (no) 1998-01-06
IL122618A (en) 2002-07-25
GB9726766D0 (en) 1998-02-18
WO1997002821A2 (en) 1997-01-30
CH692045A5 (de) 2002-01-15
IL122618A0 (en) 1998-08-16
CA2226214C (en) 2007-04-17
FI980023A (fi) 1998-01-07
AU697571B2 (en) 1998-10-08
HK1009751A1 (en) 1999-06-11
CN1091596C (zh) 2002-10-02
DE19681478T1 (de) 1998-07-02
LU90190B1 (de) 1998-03-02
EP0839035A2 (en) 1998-05-06
WO1997002821A3 (en) 1997-02-20
ZA965745B (en) 1997-01-27
AT407832B (de) 2001-06-25
MX9710401A (es) 1998-07-31
CN1194582A (zh) 1998-09-30
GB2317615B (en) 1998-09-02
NZ311796A (en) 1999-06-29
NO980055L (no) 1998-03-06
EP0839035B1 (en) 2002-10-02
CA2226214A1 (en) 1997-01-30
ATA906196A (de) 2000-11-15
ES2137888B1 (es) 2001-01-01
SE9800016D0 (sv) 1998-01-07
DE19681478B4 (de) 2006-09-21
ES2137888A1 (es) 1999-12-16
IN185384B (fi) 2001-01-13
SE9800016L (sv) 1998-01-07

Similar Documents

Publication Publication Date Title
FI980023A0 (fi) Sienilääke, siihen soveltuva yhdiste, menetelmä niiden valmistamiseksi ja menetelmä niiden käyttämiseksi
FI972332A0 (fi) Verisuonitukoksia estävä uusi formulaatio, menetelmä sen valmistamiseksi ja sen käyttö
FI960889A0 (fi) Naftyyliyhdisteitä, välituotteita, koostumuksia ja menetelmiä
FI891021A (fi) Menetelmä lääkeaineina käyttökelpoisten 1,2,4-triatsolijohdannaisten valmistamiseksi
FI971354A0 (fi) Antineoplastiset kaakaouutteet, niiden valmistusmenetelmät ja käyttö
FI905302A0 (fi) Mikrobien vastainen menetelmä ja valmiste, joissa käytetään tyyppiä II olevaa endoglykosidaasia ja mikrobien vastaista ainetta
FI973522A (fi) Vesipitoisia, lesitiinipohjaisia irrotteita ja menetelmät niiden käyttämiseksi
FI950119A0 (fi) Ulkoinen miehen katetri, sovitin ja menetelmiä sen käyttämiseksi ja valmistamiseksi
FI963185A0 (fi) Hematopoieettinen proteiini ja materiaalit ja menetelmät sen valmistamiseksi
FI941137A0 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI955051A (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FI961219A0 (fi) Kemialliset yhdisteet, niiden valmistus ja käyttö
FI970079A (fi) Fungisidinen koostumus ja menetelmä sieni-infektion kontrolloimiseen
FI972245A (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
FI963866A0 (fi) Immuuniterapeuttinen aine ja sen käyttö
FI941914A0 (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
FI964310A0 (fi) Imidatsolijohdannainen ja menetelmä sen valmistamiseksi
FI970103A (fi) Mikro-organismeja sisältävä raekoostumus, menetelmä sen valmistamiseksi ja sen käyttö
FI970657A (fi) Koostumuksia ja menetelmiä tuhohyönteisten torjumiseksi
FI970098A0 (fi) Menetelmä ja yhdiste hiustenlähdön hoitamiseksi
FI894323A0 (fi) Antimikrobiaalinen ainekoostumus, menetelmä ja käyttö
FI972702A (fi) Uusi kladraattiyhdiste ja sen valmistusmenetelmä sekä tätä yhdistettä sisältävä pinnoituskoostumus
KR970006290A (ko) 광학 활성 트리아졸 유도체, 이의 제조방법, 이를 함유하는 항진균제 및 이의 사용방법
FI974002A0 (fi) Menetelmä ranitidiinihydrokloridi 1 muodon valmistamiseksi
FI88310B (fi) Foerfarande och medel foer bestaemning av urea

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119357

Country of ref document: FI

MA Patent expired